Agencies | Governor
Virginia Regulatory Town Hall
Department of Health Professions
Department of Health Professions
Regulations Governing the Prescription Monitoring Program [18 VAC 76 ‑ 20]
This action is exempt from the executive branch review process.
Definition of covered substances
General Information
Action Summary On July 1, 2018, the Code was changed to include the following in the covered substances that must be reported to the Prescription Monitoring Program: 1) Schedule V drugs for which a prescription is required; 2) the drug naloxone; and 3) cannabidiol oil or THC-A oil dispensed by a pharmaceutical processor in Virginia.
Chapters Affected Only affects this chapter.
Exempt from APA Yes, this action is exempt from Article 2 of the Administrative Process Act.
Exempt Citation: 2.2-4006
RIS Project Yes  [005571]
Associated Mandates Addition of covered substances to Prescription Monitoring Program
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
8337 Final Stage complete. This regulation became effective on 10/03/2018.
Contact Information
Name / Title: Ralph Orr  / Program Manager
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address:
Phone: (804)367-4523    FAX: (804)527-4470   

This person is the primary contact for this chapter.